Related Experiment Video

Updated: Aug 8, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Repression of AIM-1 kinase mRNA as part of a program of genes regulated by Mpl ligand

Y Zhang1, S Sun, W C Chen

  • 1Department of Biochemistry and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

Biochemical and Biophysical Research Communications
|June 13, 2001
PubMed

Insights

Megakaryocyte (MK) polyploidization, essential for platelet production, is regulated by c-Mpl ligand. This study reveals AIM-1 kinase downregulation via transcriptional control is crucial for MK endomitosis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Hematopoiesis

Background:

  • Megakaryocytes (MKs) are precursors to platelets, vital for hemostasis and thrombosis.
  • MK development involves endomitosis, a cell cycle allowing polyploidy without cell division.
  • The c-Mpl receptor ligand regulates this differentiation process.

Purpose of the Study:

  • To identify genes regulated during Mpl ligand-induced megakaryocyte differentiation.
  • To investigate the role of specific kinases, like AIM-1, in megakaryocyte polyploidization.

Main Methods:

  • Differential display PCR and degenerate cloning of kinases were employed.
  • Analysis focused on gene expression changes induced by Mpl ligand in megakaryocytes.
  • Transcriptional rates and message stability were assessed.

Main Results:

  • Mpl ligand induced genes encoding metabolic proteins (e.g., carnitine palmitoyltransferase).
  • AIM-1 kinase mRNA levels were significantly downregulated by Mpl ligand.
  • Downregulation of AIM-1 occurred at the transcriptional level, not due to message instability.

Conclusions:

  • Transcriptional regulation of AIM-1 kinase is implicated in megakaryocyte polyploidization.
  • AIM-1 downregulation is a key event during Mpl ligand-driven endomitosis.
  • These findings highlight the importance of specific gene regulation in megakaryocyte development.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...